ANKRD26 |
0 |
0 |
2021-04-14 |
FAM175A |
0 |
0 |
2021-04-14 |
NAA15 |
3 |
0 |
2021-04-13 |
OFD1 |
3 |
0 |
2021-04-13 |
MITF |
3 |
0 |
2021-04-13 |
16p13.11 recurrent region (BP2-BP3) (includes MYH11) |
3 |
2 |
2021-04-12 |
15q11.2 recurrent region (BP1-BP2) (includes NIPA1) |
3 |
40: Dosage sensitivity unlikely |
2021-04-12 |
PLP1 |
3 |
3 |
2021-04-12 |
FGFR1 |
3 |
0 |
2021-04-05 |
RPS19 |
3 |
0 |
2021-03-24 |
CHM |
3 |
0 |
2021-03-24 |
ATP7A |
3 |
0 |
2021-03-24 |
BTK |
3 |
0 |
2021-03-24 |
GLA |
3 |
0 |
2021-03-24 |
TIMM8A |
3 |
0 |
2021-03-24 |
ASTN2 |
1 |
0 |
2021-03-09 |
FOXG1 |
3 |
0 |
2021-03-09 |
RB1 |
3 |
0 |
2021-03-09 |
DLL1 |
3 |
0 |
2021-03-09 |
MECP2 |
3 |
0 |
2021-02-22 |
SALL1 |
1 |
0 |
2021-01-27 |
PHF6 |
3 |
0 |
2021-02-24 |
NR5A1 |
3 |
0 |
2021-02-24 |
GDF5 |
3 |
0 |
2021-02-24 |
Xq28 region (includes MECP2) |
0 |
3 |
2021-02-22 |
UNC93A |
40: Dosage sensitivity unlikely |
0 |
2021-02-03 |
TPSD1 |
40: Dosage sensitivity unlikely |
0 |
2021-02-03 |
TIGD6 |
40: Dosage sensitivity unlikely |
0 |
2021-02-03 |
TEX26 |
40: Dosage sensitivity unlikely |
0 |
2021-02-03 |
SPERT |
40: Dosage sensitivity unlikely |
0 |
2021-02-03 |
SLC6A18 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
SLC22A14 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
SIGLEC5 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
SEC14L4 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
SDR42E1 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
RNF32 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
RABL2A |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
PSORS1C2 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
PCDHGA8 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
NUDT13 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
KRT37 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
KRT24 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
KLK12 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
HTN3 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
HSD17B13 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
GUCA1C |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
GRIN3B |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
GEN1 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
GAB4 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
FMO2 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
EXO5 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
EFCAB13 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
DNAJC28 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
CYP3A43 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
COL6A5 |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
COL16A1 |
40: Dosage sensitivity unlikely |
0 |
2021-02-01 |
BPHL |
40: Dosage sensitivity unlikely |
0 |
2021-02-02 |
CYLD |
3 |
0 |
2021-02-10 |
FOXL2 |
3 |
0 |
2021-02-09 |
CUL4B |
3 |
0 |
2021-02-09 |
LAMP2 |
3 |
0 |
2021-02-09 |
UPF3B |
3 |
0 |
2021-02-09 |
MGP |
30: Gene associated with autosomal recessive phenotype |
0 |
2021-02-08 |
AVPR2 |
3 |
0 |
2021-02-01 |
GPC3 |
3 |
0 |
2021-01-27 |
SH2D1A |
3 |
0 |
2021-01-27 |
GAGE2B |
Not yet evaluated |
Not yet evaluated |
2021-01-18 |
GAGE2C |
Not yet evaluated |
Not yet evaluated |
2021-01-18 |